Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Metformin hydrochloride 1 g prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
pioglitazon 15 mg + metformin 1 g, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
trandolapril 1 mg + verapamilhydroklorid 240 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Theophylline 300 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
metoprololsuccinat 25 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
verapamilhydroklorid 400 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely darifenacin (as darifenacin hydrobromide) 15 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
disopyramidfosfat 100 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
vattenfritt teofyllin 600 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
orfenadrincitrat 100 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Oxycodone hydrochloride 40 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely hydrochlorothiazide 25 milligram and metoprolol tartrate 200 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
nifedipin 90 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely isosorbide mononitrate 60 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
kinidinsulfat 300 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
oxikodonhydroklorid 160 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely isosorbide dinitrate 40 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
järn(II)glycinsulfat 562,5 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
metoprololsuccinat 50 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely felodipine 2.5 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely mirabegron 25 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
loratadin 5 mg + pseudoefedrinsulfat 120 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Tramadol hydrochloride 400 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Mirabegron 50 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
metronidazol 750 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
metamfetaminhydroklorid 10 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Isosorbide mononitrate 40 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Sodium valproate 500 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
guajfenesin 600 mg + pseudoefedrin 60 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
prokainamidhydroklorid 250 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Nicotinic acid 750 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
klorfenaminmaleat 8 mg + metskopolaminnitrat 2,5 mg + pseudoefedrinhydroklorid 120 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
bupropionhydroklorid 100 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Fesoterodine fumarate 8 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Morphine sulfate 100 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
bupropionhydroklorid 300 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
bupropionhydroklorid 200 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely nicotinic acid 500 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
guajfenesin 1 200 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely felodipine 10 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Fluvastatin (as fluvastatin sodium) 80 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
diltiazem 180 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely lithium carbonate 200 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
takrolimus 750 mikrogram, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely carbamazepine 200 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
divalproexnatrium 500 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Nifedipine 30 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
desloratadin 2,5 mg + pseudoefedrin 120 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
fexofenadinhydroklorid 60 mg + pseudoefedrinhydroklorid 120 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Metoclopramide hydrochloride 15 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
diltiazem 300 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Felodipine 5 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely gliclazide 30 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Nifedipine 40 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Darifenacin (as darifenacin hydrobromide) 7.5 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
järn(II)sulfat 325 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
fexofenadinhydroklorid 180 mg + pseudoefedrinhydroklorid 240 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Nisoldipine 30 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely fesoterodine fumarate 4 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Diclofenac sodium 75 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
isradipin 5 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
niacin 375 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely verapamil hydrochloride 120 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely oxybutynin hydrochloride 5 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely oxybutynin hydrochloride 10 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Nicotinic acid 1 g and simvastatin 20 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Nicotinic acid 750 mg and simvastatin 20 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely nicotinic acid 500 milligram and simvastatin 20 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely guanfacine (as guanfacine hydrochloride) 1 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely guanfacine (as guanfacine hydrochloride) 2 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely guanfacine (as guanfacine hydrochloride) 3 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely guaifenesin 1.2 gram and pseudoephedrine hydrochloride 120 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Guanfacine (as guanfacine hydrochloride) 4 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely guaifenesin 600 milligram and pseudoephedrine hydrochloride 60 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Dextromethorphan hydrobromide 60 mg and guaifenesin 1.2 g prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely dextromethorphan hydrobromide 30 milligram and guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
amoxicillin, vattenfritt (som amoxicillin) 775 milligram, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Nevirapine 50 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Metoprolol tartrate (as metoprolol succinate) 25 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Metoprolol tartrate (as metoprolol succinate) 50 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely metoprolol tartrate (as metoprolol succinate) 100 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely metoprolol tartrate (as metoprolol succinate) 200 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
fostemsavir 600 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely ferrous sulfate 325 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely upadacitinib 15 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Carbidopa 25 mg and levodopa 100 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely cefaclor 375 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Ranolazine 375 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely paroxetine (as paroxetine hydrochloride) 25 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Aminophylline hydrate 225 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely aminophylline hydrate 350 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Biperiden hydrochloride 4 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely tramadol hydrochloride 50 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Venlafaxine (as venlafaxine hydrochloride) 37.5 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Venlafaxine (as venlafaxine hydrochloride) 225 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Budesonide 9 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Quetiapine (as quetiapine fumarate) 50 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Quetiapine (as quetiapine fumarate) 150 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Clarithromycin (as clarithromycin citrate) 500 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|